Literature DB >> 7972778

Activity of Crohn disease assessed by measurement of superior mesenteric artery flow with Doppler US.

J A van Oostayen1, M N Wasser, R A van Hogezand, G Griffioen, A de Roos.   

Abstract

PURPOSE: To test the hypothesis that increased blood flow in the superior mesenteric artery (SMA) reflects disease activity in patients with Crohn disease.
MATERIALS AND METHODS: Duplex Doppler sonographic measurements of SMA blood flow volume were obtained in 10 patients with active Crohn disease, 10 patients with chronic inactive Crohn disease, and 10 healthy volunteers. Disease activity was determined with clinical and laboratory indicators.
RESULTS: Interstudy reproducibility of repeated SMA flow volume measurements was good (r = .98). A marked increase in SMA flow volume was noted in patients with active disease compared with patients with inactive disease and healthy volunteers: 1,588 mL/min +/- 576 versus 288 mL/min +/- 113 and 417 mL/min +/- 147, respectively (P < .05 for both comparisons).
CONCLUSION: Activity of Crohn disease causes a substantial increase in SMA flow volume. Measurement of SMA blood flow may be an important noninvasive, readily available, inexpensive tool that can be used to monitor Crohn disease objectively.

Entities:  

Mesh:

Year:  1994        PMID: 7972778     DOI: 10.1148/radiology.193.2.7972778

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Spiral CT demonstration of hypervascularity in Crohn disease: "vascular jejunization of the ileum" or the "comb sign".

Authors:  M A Meyers; P V McGuire
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

3.  Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.

Authors:  J W Arndt; M I Grootscholten; R A van Hogezand; G Griffioen; C B Lamers; E K Pauwels
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

Review 4.  Ultrasonographic imaging of inflammatory bowel disease in pediatric patients.

Authors:  Liliana Chiorean; Dagmar Schreiber-Dietrich; Barbara Braden; Xin-Wu Cui; Reiner Buchhorn; Jian-Min Chang; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

5.  Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound.

Authors:  G Maconi; F Parente; S Bollani; V Imbesi; S Ardizzone; A Russo; G Bianchi Porro
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

6.  Assessment of Crohn's disease activity by doppler ultrasound of superior mesenteric artery and mural arteries in thickened bowel wall: cross-sectional study.

Authors:  Ivica Sjekavica; Vinka Barbarić-Babić; Zeljko Krznarić; Melita Molnar; Silvija Cuković-Cavka; Ranka Stern-Padovan
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

7.  Doppler US measurement of the superior mesenteric artery blood flow in children and adolescents.

Authors:  Juliana C Eloi; Matias Epifanio; José V N Spolidoro; Pablo Camargo; Juliana Krebs; Mariana D Mizerkowski; Matteo Baldisserotto
Journal:  Pediatr Radiol       Date:  2012-09-07

8.  Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.

Authors:  Sarah Alrubia; Jialin Mao; Yuan Chen; Jill Barber; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2022-09-03       Impact factor: 5.577

9.  Crohn's disease activity assessed by Doppler sonography: the role of aortic flow parameters.

Authors:  Thais Guaraná Andrade; Homero Soares Fogaça; Celeste Carvalho Siqueira Elia; Melissa Tassano Pitrowsky; Heitor Siffert Pereira de Souza
Journal:  Clinics (Sao Paulo)       Date:  2013-04       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.